← Leaderboards
Eugene P. Rhee
Massachusetts General Hospital
$7,229,659
Attributed
$10,474,377
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,474,377 · 6
By mechanism
R01$7,476,117 · 3
U01$2,168,441 · 1
K08$799,860 · 1
F32$29,959 · 1
Top collaborators
- Tariq Shafi5 shared
- Morgan Erika Grams4 shared
- Sushrut S. Waikar4 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Thomas J Gardella$10,202,128
- Michael Mannstadt$4,555,232
- John T Potts$1,716,912
- Henry T Keutmann$5,408,179
- Petra Simic$865,500
Others in their field
Top investigators on “Metabolomics”
- Jeffrey P Krischer · University Of South Florida$138,267,392
- Mine Cicek · Mayo Clinic Rochester$80,157,953
- Stephen Norman Thibodeau · Mayo Clinic Rochester$70,215,522
- Richard Gibbs · Baylor College Of Medicine$68,573,551
- Richard A Gibbs · Baylor College Of Medicine$62,998,471
- Leonardo Trasande · New York University School Of Medicine$57,546,121
Research focus
MetabolomicsKidney DiseasesBloodKidneyCohortLinkEnd Stage Renal FailureInsightInterestBaseRenal FunctionDisease ProgressionPlasmaMetabolicCessation Of LifeAffectChronic Kidney FailureFundingInvestigationPathogenesisGlomerular Filtration RateCohort StudiesPathway InteractionsEpidemiology
Grant awards (24)
Multi-Omics and Chronic Kidney Disease: Correlation with Histology$667,051
R01 · FY2025 · DK
Kidney Glycolysis as the Mammalian Phosphate Sensor$485,475
R01 · FY2025 · DK · contact PI
Multi-Omics and Chronic Kidney Disease: Correlation with Histology$640,290
R01 · FY2024 · DK
Kidney Glycolysis as the Mammalian Phosphate Sensor$466,057
R01 · FY2024 · DK · contact PI
Multi-Omics and Chronic Kidney Disease: Correlation with Histology$713,017
R01 · FY2023 · DK
Metabolomics of Uremic Symptoms in Dialysis Patients$538,379
R01 · FY2023 · NR · contact PI
Kidney Glycolysis as the Mammalian Phosphate Sensor$481,073
R01 · FY2023 · DK · contact PI
Multi-Omics and Chronic Kidney Disease: Correlation with Histology$762,855
R01 · FY2022 · DK
Metabolomics of Uremic Symptoms in Dialysis Patients$568,701
R01 · FY2022 · NR · contact PI
Kidney Glycolysis as the Mammalian Phosphate Sensor$481,814
R01 · FY2022 · DK · contact PI
Metabolomics of Uremic Symptoms in Dialysis Patients$537,959
R01 · FY2020 · NR · contact PI
Metabolomics of Uremic Symptoms in Dialysis Patients$540,865
R01 · FY2019 · NR · contact PI
Metabolomics of CKD and CKD Progression$395,000
U01 · FY2019 · DK · contact PI
Metabolomics of Uremic Symptoms in Dialysis Patients$592,581
R01 · FY2018 · NR · contact PI
Metabolomics of CKD and CKD Progression$439,065
U01 · FY2018 · DK · contact PI
Metabolomics of CKD and CKD Progression$439,065
U01 · FY2017 · DK · contact PI
Metabolomics of CKD and CKD Progression$448,228
U01 · FY2016 · DK · contact PI
Metabolomics of CKD and CKD Progression$447,083
U01 · FY2015 · DK · contact PI
Metabolite Profiling and Cardiovascular Mortality in End-stage Renal Disease$160,116
K08 · FY2015 · DK · contact PI
Metabolite Profiling and Cardiovascular Mortality in End-stage Renal Disease$160,116
K08 · FY2014 · DK · contact PI
Metabolite Profiling and Cardiovascular Mortality in End-stage Renal Disease$160,116
K08 · FY2013 · DK · contact PI
Metabolite Profiling and Cardiovascular Mortality in End-stage Renal Disease$159,796
K08 · FY2012 · DK · contact PI
Metabolite Profiling and Cardiovascular Mortality in End-stage Renal Disease$159,716
K08 · FY2011 · DK · contact PI
Metabolomic Biomarkers of CKD$29,959
F32 · FY2010 · DK · contact PI